Phase II proof-of-concept Trial of clarithromycin/clofazimine/rifabutin in Type 1 Diabetes Mellitus Patients

Trial Profile

Phase II proof-of-concept Trial of clarithromycin/clofazimine/rifabutin in Type 1 Diabetes Mellitus Patients

Planning
Phase of Trial: Phase II

Latest Information Update: 28 Jul 2014

At a glance

  • Drugs Clarithromycin/clofazimine/rifabutin (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Proof of concept; Therapeutic Use
  • Sponsors RedHill Biopharma
  • Most Recent Events

    • 28 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top